Onxeo to attend upcoming investor events
Paris (France), Copenhagen (Denmark) – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), an innovative company specializing in the development of orphan oncology drugs, today announces its participation to financial conferences in the coming months.
During these conferences, Onxeo’s management will present the recent achievements and the growth strategy of the Company to institutional and individual investors.
Meetings with institutional investors:
- Société Générale - Biotech & Medtech CEO conference: Paris, November 5, 2015
- Natixis Small and Midcap Conference: Paris, November 24, 2015
- ODDO Forum: Lyon, January 7-8, 2016
- JP Morgan Healthcare Conference: San Francisco, January 11-15, 2016
Meeting with individual investors:
- Actionaria: Paris, November 20-21, 2015